XML 53 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment The following table presents certain financial data for the Company’s reportable segment (in thousands):
Three months ended,
20252024
Clinical trial expenses$4,192 $2,302 
Employee related research and development expenses2,298 2,243 
Chemistry, manufacturing and controls expenses646 1,194 
Other research and development expenses1,136 1,887 
Contract and grant reimbursements(489)(67)
Employee related general and administrative expenses1,087 919 
Professional fees and other general and administrative expenses1,866 1,762 
Other segment items473 1,587 
Segment net loss$11,209 $11,827 

March 31,
2025
December 31,
2024
Total segment assets$28,144 $28,178